Meeting of the President's Council on Bioethics, 47603 [E8-18830]
Download as PDF
Federal Register / Vol. 73, No. 158 / Thursday, August 14, 2008 / Notices
Board of Governors of the Federal Reserve
System, August 11, 2008.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E8–18828 Filed 8–13–08; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the President’s Council on
Bioethics
Department of Health and
Human Services, Office of Public Health
and Science, The President’s Council on
Bioethics.
ACTION: Notice.
sroberts on PROD1PC70 with NOTICES
AGENCY:
SUMMARY: The President’s Council on
Bioethics (Edmund D. Pellegrino, MD,
Chairman) will hold its thirty-fourth
meeting, at which it will discuss its
projected white paper on ethical
questions in medical care reform as well
as hear and discuss presentations on
two additional topics, i.e., exercises of
conscience in the practice of the health
professions and futility in clinical
judgments at the end of life. Subjects
discussed at past Council meetings
(although not on the agenda for the
September 2008 meeting) include:
Therapeutic and reproductive cloning,
assisted reproduction, reproductive
genetics, neuroscience, aging
retardation, organ transplantation,
personalized medicine, and lifespanextension. Publications issued by the
Council to date include: Human Cloning
and Human Dignity: An Ethical Inquiry
(July 2002); Beyond Therapy:
Biotechnology and the Pursuit of
Happiness (October 2003); Being
Human: Readings from the President’s
Council on Bioethics (December 2003);
Monitoring Stem Cell Research (January
2004), Reproduction and Responsibility:
The Regulation of New Biotechnologies
(March 2004), Alternative Sources of
Human Pluripotent Stem Cells: A White
Paper (May 2005), Taking Care: Ethical
Caregiving in Our Aging Society
(September 2005), and Human Dignity
and Bioethics: Essays Commissioned by
the President’s Council on Bioethics
(March 2008). Reports are forthcoming
on three topics: Controversies in the
determination of death; organ donation,
procurement, allocation, and
transplantation; and newborn screening.
DATES: The meeting will take place
Thursday, September 11, 2008, from 9
a.m. to 5 p.m., ET; and Friday,
VerDate Aug<31>2005
15:57 Aug 13, 2008
Jkt 214001
September 12, 2008, from 9 a.m. to
noon, ET.
ADDRESSES: Hotel Palomar Arlington,
1121 North 19th Street, Arlington, VA
22209. Phone 703–351–9170.
FOR FURTHER INFORMATION CONTACT: Ms.
Diane M. Gianelli, Director of
Communications, The President’s
Council on Bioethics, 1425 New York
Avenue, NW., Suite C100, Washington,
DC 20005. Telephone: 202/296–4669. Email: info@bioethics.gov. Web site:
https://www.bioethics.gov.
SUPPLEMENTARY INFORMATION: The
meeting agenda will be posted at
https://www.bioethics.gov. The Council
encourages public input, either in
person or in writing. At this meeting,
interested members of the public may
address the Council, beginning at 11:45
a.m. on Friday, September 12.
Comments are limited to no more than
five minutes per speaker or
organization. As a courtesy, please
inform Ms. Diane M. Gianelli, Director
of Communications, in advance of your
intention to make a public statement,
and give your name and affiliation. To
submit a written statement, mail or email it to Ms. Gianelli at one of her
contact addresses given above.
Dated: August 4, 2008.
F. Daniel Davis,
Executive Director, The President’s Council
on Bioethics.
[FR Doc. E8–18830 Filed 8–13–08; 8:45 am]
BILLING CODE 4154–06–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–08–08AJ]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–4766 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
47603
Proposed Project
Focus Group Testing to Effectively
Plan and Tailor Cancer Prevention and
Control Communication Campaigns—
New—Division of Cancer Prevention
and Control (DCPC), National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The mission of CDC’s Division of
Cancer Prevention and Control (DCPC)
is to reduce the burden of cancer in the
United States through cancer
prevention, reduction of risk, early
detection, better treatment, and
improved quality of life for cancer
survivors. Toward this end, DCPC
supports the scientific development,
implementation, and evaluation of
various health communication
campaigns with an emphasis on specific
cancer burdens. This process requires
testing of messages, concepts, and
materials prior to their final
development and dissemination.
CDC requests OMB approval of a
generic information collection request to
develop and test cancer prevention and
control messages, including, but not
limited to, colorectal and gynecologic
cancers. Because communication
campaigns will vary according to the
type of cancer, qualitative dimensions of
the message, and the type of
respondents, DCPC has developed a
reference set of questions that can be
tailored for use in a variety of focus
group-based information collections.
The discussion guide for each focus
group will be drawn from the reference
set of pre-approved questions.
Insights gained from the focus groups
will assist in the development and/or
refinement of messages and materials to
ensure that the general public and other
key audiences clearly understand the
messages and are motivated to adopt the
desired action. Screening information
will be collected from potential
respondents in order to identify those
who represent key audiences for
specific messages.
The average burden for participating
in a focus group discussion will be two
hours. Over a three-year period, DCPC
will conduct or sponsor up to 72 focus
groups per year with an average of 12
respondents each. There are no costs to
respondents except their time. The total
estimated annualized burden hours are
1,814.
E:\FR\FM\14AUN1.SGM
14AUN1
Agencies
[Federal Register Volume 73, Number 158 (Thursday, August 14, 2008)]
[Notices]
[Page 47603]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18830]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the President's Council on Bioethics
AGENCY: Department of Health and Human Services, Office of Public
Health and Science, The President's Council on Bioethics.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The President's Council on Bioethics (Edmund D. Pellegrino,
MD, Chairman) will hold its thirty-fourth meeting, at which it will
discuss its projected white paper on ethical questions in medical care
reform as well as hear and discuss presentations on two additional
topics, i.e., exercises of conscience in the practice of the health
professions and futility in clinical judgments at the end of life.
Subjects discussed at past Council meetings (although not on the agenda
for the September 2008 meeting) include: Therapeutic and reproductive
cloning, assisted reproduction, reproductive genetics, neuroscience,
aging retardation, organ transplantation, personalized medicine, and
lifespan-extension. Publications issued by the Council to date include:
Human Cloning and Human Dignity: An Ethical Inquiry (July 2002); Beyond
Therapy: Biotechnology and the Pursuit of Happiness (October 2003);
Being Human: Readings from the President's Council on Bioethics
(December 2003); Monitoring Stem Cell Research (January 2004),
Reproduction and Responsibility: The Regulation of New Biotechnologies
(March 2004), Alternative Sources of Human Pluripotent Stem Cells: A
White Paper (May 2005), Taking Care: Ethical Caregiving in Our Aging
Society (September 2005), and Human Dignity and Bioethics: Essays
Commissioned by the President's Council on Bioethics (March 2008).
Reports are forthcoming on three topics: Controversies in the
determination of death; organ donation, procurement, allocation, and
transplantation; and newborn screening.
DATES: The meeting will take place Thursday, September 11, 2008, from 9
a.m. to 5 p.m., ET; and Friday, September 12, 2008, from 9 a.m. to
noon, ET.
ADDRESSES: Hotel Palomar Arlington, 1121 North 19th Street, Arlington,
VA 22209. Phone 703-351-9170.
FOR FURTHER INFORMATION CONTACT: Ms. Diane M. Gianelli, Director of
Communications, The President's Council on Bioethics, 1425 New York
Avenue, NW., Suite C100, Washington, DC 20005. Telephone: 202/296-4669.
E-mail: info@bioethics.gov. Web site: https://www.bioethics.gov.
SUPPLEMENTARY INFORMATION: The meeting agenda will be posted at https://
www.bioethics.gov. The Council encourages public input, either in
person or in writing. At this meeting, interested members of the public
may address the Council, beginning at 11:45 a.m. on Friday, September
12. Comments are limited to no more than five minutes per speaker or
organization. As a courtesy, please inform Ms. Diane M. Gianelli,
Director of Communications, in advance of your intention to make a
public statement, and give your name and affiliation. To submit a
written statement, mail or e-mail it to Ms. Gianelli at one of her
contact addresses given above.
Dated: August 4, 2008.
F. Daniel Davis,
Executive Director, The President's Council on Bioethics.
[FR Doc. E8-18830 Filed 8-13-08; 8:45 am]
BILLING CODE 4154-06-P